16 November 2018
CTA Editor Henry Kerali explores what impact blockchain could have on clinical research
1 November 2018
CTA’s Anne-Marie Mongan unpacks the tangible benefits of going virtual
23 October 2018
Elucidating Opportunities for Cost Reduction of Clinical Trials Through Supply Management Optimization
Anthony Zuccarello, Associate Director, IRT and Global Clinical Supply Strategy, Amicus Therapeutics, offers insight on how to create efficiencies within the clinical supply chain
7 August 2018
CTA’s Anne-Marie Mongan explores whether the tech industry’s foray into health care is a benefit or hindrance to the industry
27 June 2018
The first accelerated approval for a tumor-agnostic drug was granted by the FDA in May 2017, enabling patients with any locally advanced or metastatic solid tumor expressing particular biomarkers for...
21 June 2018
Michael Stephenson & Ignacio Gomez-Arroyo Bernabeu, Janssen, examine the use of just in time labeling within the clinical supply chain
9 May 2018
Francesco Spoto, Clinical Project Manager, analyzes the opportunities of using IRT solutions for accurate supply forecasting
8 May 2018
The FDA has granted priority review for Merck’s Keytruda (pembrolizumab) + Alimta (pemetrexed injection) + platinum-based chemotherapy combination as a first-line treatment for patients with metastatic non-squamous, non-small cell lung...
23 April 2018
Follow-up results from Phase IIb clinical trials demonstrating the efficacy of Synthetic Biologics’ ribaxamase (SYN-004) in protecting the gut microbiome in patients receiving IV ceftriaxone were presented at the 2018...
1 March 2018
The number of first approvals for biosimilars in the US, Japan, or EU has increased significantly in the past two years, breaking the stagnation of the three years prior, with...